Translate
Journey Medical Corp
About
Journey Medical Corp (NASDAQ:DERM) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™
Mar 25 2026
Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Mar 18 2026
Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026
Dec 10 2025
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Nov 12 2025
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights